Insulin glargine new formulation (HOE901)

DRUG2 trials

Sponsors

Sanofi

Conditions

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

Phase 3

Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus

CompletedNCT01689142

SanofiType 2 Diabetes Mellitus

Start: 2012-09-30End: 2014-06-30Updated: 2014-06-05

Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus

CompletedNCT01689129

SanofiType 1 Diabetes Mellitus

Start: 2012-09-30End: 2014-04-30Updated: 2014-06-09

Related Papers

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).

2016-02-0165 citations

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

2016-01-2187 citations